RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Lilly Insulin Glargine Versus Lantus((R)) in Type 2 Diabetes Mellitus Patients: India and East Asia Subpopulation Analyses of the ELEMENT 5 Study.

Lilly Insulin Glargine Versus Lantus((R)) in Type 2 Diabetes Mellitus Patients: India and East Asia Subpopulation Analyses of the ELEMENT 5 Study.

Add to Collection
2019 Aug Others V Mohan, KJ Ahn, YM Cho, RK Sahay… - Clinical Drug …, 2019 - Springer

Full Author : ['Mohan, Viswanathan', 'Ahn, Kyu Jeung', 'Cho, Young Min', 'Sahay, Rakesh Kumar', 'Huang, Chien-Ning', 'Kalra, Sanjay', 'Chadha, Manoj', 'Bhattacharya, Indranil', 'Kim, So Yeon', 'Spaepen, Erik']
Journal Title : Clinical drug investigation
Chapter : Section3
Journal Year : 2019
Cited by : 1.0

BACKGROUND AND OBJECTIVES: Lilly insulin glargine (LY IGlar; Basaglar((R))) and the reference insulin glargine product (IGlar; Lantus((R))) are basal insulin glargine analogs with identical amino acid sequence and similar pharmacological profiles. ELEMENT..... Read More

Keywords : ["type diabetes mellitus patient india", "lilly insulin glargine versus lantusr", "east asia subpopulation analysis", "element study"]
PubMed Link : https://link.springer.com/article/10.1007/s40261-019-00798-1
Google Scholar Link : https://scholar.google.com/scholar?cites=391147465606496207&as_sdt=2005&sciodt=0,5&hl=en&num=20